首页> 外文期刊>海南医科大学学报(英文版) >Effect of doubling-dose atorvastatin intervention on lipid metabolism, insulin resistance and carotid atherosclerosis in patients with type 2 diabetes mellitus
【24h】

Effect of doubling-dose atorvastatin intervention on lipid metabolism, insulin resistance and carotid atherosclerosis in patients with type 2 diabetes mellitus

机译:阿托伐他汀加倍剂量对2型糖尿病患者脂质代谢,胰岛素抵抗和颈动脉粥样硬化的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To study the effect of doubling-dose atorvastatin intervention on lipid metabolism, insulin resistance and carotid atherosclerosis in patients with type 2 diabetes mellitus. Methods:A total of 118 patients with type 2 diabetes mellitus treated in our hospital between May 2013 and December 2016 were collected, random number table was used to divide them into the single dose group (n=59) who received single-dose atorvastatin (20 mg/time, 1 times/d) therapy and the double dose group (n=59) who received doubling-dose atorvastatin (40 mg/time, 1 times/d) therapy, and both therapies lasted for 3 months. Serum levels of lipid metabolism indexes, insulin resistance indexes and carotid atherosclerosis-related indexes were compared between the two groups of patients before and after treatment.Results: Before treatment, differences in serum levels of lipid metabolism indexes, insulin resistance indexes and carotid atherosclerosis-related indexes were not statistically significant between two groups of patients. After treatment, serum lipid metabolism indexes TC, TG, FFA and LDL-C contents of observation group were lower than those of control group while HDL-C content was higher than that of control group; serum insulin resistance indexes INS and HOMA-IR levels were lower than those of control group while HOMA-β level was higher than that of control group; serum carotid atherosclerosis-related indexes visfatin, OPG, CysC and HMGB1 contents were lower than those of control group.Conclusions: Doubling-dose atorvastatin may be more effective in decreasing the hyperlipidemia and reducing the insulin resistance and carotid atherosclerosis in patients with type 2 diabetes mellitus.
机译:目的:研究阿托伐他汀加倍剂量对2型糖尿病患者脂质代谢,胰岛素抵抗和颈动脉粥样硬化的影响。方法:收集2013年5月至2016年12月我院收治的118例2型糖尿病患者,采用随机数字表法将单剂量阿托伐他汀(n = 59)分为单剂量组(n = 59)。 20毫克/次,1次/天)疗法和双剂量组(n = 59)接受阿托伐他汀加倍剂量(40毫克/次,1次/天)疗法,两种疗法均持续3个月。比较两组患者治疗前后的血脂代谢指标,胰岛素抵抗指数和颈动脉粥样硬化相关指标。结果:治疗前,血脂代谢指标,胰岛素抵抗指数和颈动脉粥样硬化-两组患者之间的相关指标无统计学意义。治疗后,观察组血脂代谢指标TC,TG,FFA,LDL-C含量低于对照组,而HDL-C含量高于对照组。血清胰岛素抵抗指数INS和HOMA-IR水平低于对照组,而HOMA-β水平高于对照组。血清颈动脉粥样硬化相关指标visfatin,OPG,CysC和HMGB1含量均低于对照组。结论:阿托伐他汀加倍剂量可能在降低2型糖尿病患者的高脂血症,降低胰岛素抵抗和颈动脉粥样硬化方面更有效。的。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第11期|47-50|共4页
  • 作者单位

    Endocrinology Department, Shangluo Central Hospital in Shaanxi Province, Shangluo 726000, Chinaa;

    Endocrinology Department, Shangluo Central Hospital in Shaanxi Province, Shangluo 726000, Chinaa;

    The Second Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712000, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号